Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors

Almost all prostate cancers respond to androgen deprivation treatment but many recur. We postulated that risk of hormone escape -frequency and delay- are influenced by hormone therapy modalities. More, hormone therapies induce crucial biological changes involving androgen receptors; some might be ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Guyader, Charlotte, Céraline, Jocelyn, Gravier, Eléonore, Morin, Aurélie, Michel, Sandrine, Erdmann, Eva, de Pinieux, Gonzague, Cabon, Florence, Bergerat, Jean-Pierre, Poupon, Marie-France, Oudard, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412862/
https://www.ncbi.nlm.nih.gov/pubmed/22879924
http://dx.doi.org/10.1371/journal.pone.0042252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412862/
https://www.ncbi.nlm.nih.gov/pubmed/22879924
http://dx.doi.org/10.1371/journal.pone.0042252

Ejemplares similares